Clinical Trial Update: Ertugliflozin in Chronic Heart Failure [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating ertugliflozin for chronic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Ertugliflozin (ertugliflozin)

Snippet

Sponsor: Yale University | Conditions: Heart Failure | Phase 2 | Status: RECRUITING